Home › Funds › Caligan Partners LP › IMCR
Caligan Partners LP position in IMCR
IMMUNOCORE HLDGS PLC · Health Care
Caligan Partners LP reported holding 1,381,317 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q2 2026 13F filing — a position valued at US$43.9M, representing 2.56% of its reported portfolio and ranking #10 among its reported holdings. Caligan Partners LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Caligan Partners LP's IMCR position evolved
Caligan Partners LP first disclosed a stake in IMCR in Q2 2026 at 1,381,317 shares (US$43.9M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.38M | $43.86M | New |
About IMCR and 13F data
IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 31 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$154.6M), Bellevue Group AG (US$88.5M), TANG CAPITAL MANAGEMENT LLC (US$84.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMCR
- RTW INVESTMENTS, LP 4.87M sh · $154.62M · Q2 2026
- Bellevue Group AG 2.79M sh · $88.53M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 2.65M sh · $84.12M · Q2 2026
- Vestal Point Capital, LP 1.80M sh · $57.15M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.43M sh · $45.34M · Q2 2026
- Kynam Capital Management, LP 1.38M sh · $43.66M · Q2 2026
- BVF INC/IL 1.29M sh · $41.10M · Q2 2026
- Trails Edge Capital Partners, LP 1.06M sh · $33.76M · Q2 2026
- Logos Global Management LP 600.00K sh · $19.05M · Q2 2026
- Jones Hill Capital LP 512.86K sh · $16.28M · Q2 2026
- Frazier Life Sciences Management, L.P. 484.78K sh · $15.39M · Q2 2026
- Fulcrum Asset Management LLP 470.02K sh · $14.30M · Q2 2026
More on Caligan Partners LP
FAQ
How long has Caligan Partners LP held IMCR?
Caligan Partners LP has disclosed IMCR holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Caligan Partners LP's current position in IMCR?
As of Q2 2026, Caligan Partners LP holds 1.38M shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $43.86M, representing 2.56% of its reported portfolio and ranking #10.
Has Caligan Partners LP been buying or selling IMCR?
In the latest 13F filing (Q2 2026), Caligan Partners LP newly opened its position in IMCR.
Which other funds hold IMCR?
Other major institutional holders of IMCR include RTW INVESTMENTS, LP, Bellevue Group AG, TANG CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.